title: Improvements in the minimum binding sequence of C5a: examination of His-67.
authors.affiliation: Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, Illinois 60064.
authors.forename: Y S
authors.initials: YS
authors.lastname: Or
authors.forename: R F
authors.initials: RF
authors.lastname: Clark
authors.forename: B
authors.initials: B
authors.lastname: Lane
authors.forename: K W
authors.initials: KW
authors.lastname: Mollison
authors.forename: G W
authors.initials: GW
authors.lastname: Carter
authors.forename: J R
authors.initials: JR
authors.lastname: Luly
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D002199:Capillary Permeability / Q000187:drug effects; D015936:Complement C5a / Q000138:chemical synthesis / Q000737:chemistry / Q000378:metabolism*; D006168:Guinea Pigs; D006639:Histidine; D006801:Humans; D066298:In Vitro Techniques; D008969:Molecular Sequence Data; D009504:Neutrophils / Q000276:immunology; D010446:Peptide Fragments / Q000138:chemical synthesis / Q000378:metabolism; D044087:Receptor, Anaphylatoxin C5a; D011951:Receptors, Complement / Q000037:antagonists & inhibitors / Q000378:metabolism*; D012867:Skin / Q000098:blood supply; D013329:Structure-Activity Relationship
chemical_list: D010446:Peptide Fragments; D044087:Receptor, Anaphylatoxin C5a; D011951:Receptors, Complement; D006639:Histidine; D015936:Complement C5a